Histological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy.
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (NCT00447057) | Eli Lilly and Company | 2007-03-01 |
Track Histological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy. automatically
Every clearance here is in the API, with alerts when new ones post.